Francesca Musumeci

Genoa, 16132, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 59 publications

Probing pyrazolo-pyrimidines as SIRT2 inhibitors via molecular modelling and biological assays.

Probing pyrazolo-pyrimidines as SIRT2 inhibitors via molecular modelling and biological assays.

Journal: RSC medicinal chemistry

Published: February 23, 2026

Alzheimer's Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective.

Alzheimer's Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective.

Journal: International journal of molecular sciences

Published: June 24, 2025

Investigating the potential of the SI306 Src inhibitor and its liposomal formulation in the non-small cell lung cancer treatment.

Investigating the potential of the SI306 Src inhibitor and its liposomal formulation in the non-small cell lung cancer treatment.

Journal: International journal of pharmaceutics

Published: April 07, 2025

Approaching Gallium-68 radiopharmaceuticals for tumor diagnosis: a Medicinal Chemist's perspective.

Approaching Gallium-68 radiopharmaceuticals for tumor diagnosis: a Medicinal Chemist's perspective.

Journal: European journal of medicinal chemistry

Published: April 01, 2025

Evaluation of Antitumoral Activity in a 3D Cell Model of a Src Inhibitor Prodrug for Glioblastoma Treatment.

Evaluation of Antitumoral Activity in a 3D Cell Model of a Src Inhibitor Prodrug for Glioblastoma Treatment.

Journal: Pharmaceutics

Published: April 01, 2025

Corrigendum to "Applying molecular hybridization to design a new class of pyrazolo[3,4-d] pyrimidines as Src inhibitors active in hepatocellular carcinoma" [Eur. J. Med. Chem. 280 (2024) 116929].

Corrigendum to "Applying molecular hybridization to design a new class of pyrazolo[3,4-d] pyrimidines as Src inhibitors active in hepatocellular carcinoma" [Eur. J. Med. Chem. 280 (2024) 116929].

Journal: European journal of medicinal chemistry

Published: January 30, 2025

Exploring a New Generation of Pyrimidine and Pyridine Derivatives as Anti-Influenza Agents Targeting the Polymerase PA-PB1 Subunits Interaction.

Exploring a New Generation of Pyrimidine and Pyridine Derivatives as Anti-Influenza Agents Targeting the Polymerase PA-PB1 Subunits Interaction.

Journal: Pharmaceutics

Published: June 13, 2024

Applying molecular hybridization to design a new class of pyrazolo[3,4-d]pyrimidines as Src inhibitors active in hepatocellular carcinoma.

Applying molecular hybridization to design a new class of pyrazolo[3,4-d]pyrimidines as Src inhibitors active in hepatocellular carcinoma.

Journal: European journal of medicinal chemistry

Published: April 22, 2024

Unlocking Potential and Limits of Kinase Inhibitors: The Highway to Enhanced Cancer Targeted Therapy.

Unlocking Potential and Limits of Kinase Inhibitors: The Highway to Enhanced Cancer Targeted Therapy.

Journal: Pharmaceutics

Published: April 12, 2024

Recent Advances in the Discovery of SIRT1/2 Inhibitors via Computational Methods: A Perspective.

Recent Advances in the Discovery of SIRT1/2 Inhibitors via Computational Methods: A Perspective.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 30, 2024

Discovery of a Novel Chemo-Type for TAAR1 Agonism via Molecular Modeling.

Discovery of a Novel Chemo-Type for TAAR1 Agonism via Molecular Modeling.

Journal: Molecules (Basel, Switzerland)

Published: February 16, 2024

Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment.

Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment.

Journal: International journal of molecular sciences

Published: December 20, 2023

Showing 1-12 of 59

Last Updated: 09/26/2026